Haematological cancer: Improvements with daratumumab
- PMID: 27600254
- DOI: 10.1038/nrclinonc.2016.145
Haematological cancer: Improvements with daratumumab
Comment on
-
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma.N Engl J Med. 2016 Aug 25;375(8):754-66. doi: 10.1056/NEJMoa1606038. N Engl J Med. 2016. PMID: 27557302 Clinical Trial.
References
-
- N Engl J Med. 2016 Aug 25;375(8):754-66 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
